- Home
- / Melodiol Global Health
Melodiol Global Health
Stock Price
$0.1
2024-10-29
Market Capitalization
$131.7 M
2024-10-29
Revenue
$21.6 M
FY, 2023
Melodiol Global Health Summary
Company Summary
- Overview
- Melodiol Global Health (formerly known as Creso Pharma) is a company that develops cannabis and hemp-derived therapeutic, nutraceutical, animal, and cosmetic products. It offers anibidiol, cannaQIX, vitamins and zincs, hemp oil extracts, etc.
- Type
- Public
- Status
- Active
- Founded
- 1980
- HQ
- Nedlands, AU | view all locations
- Cybersecurity rating
Table of Contents
LocationsView all
1 location detected
Nedlands, WA HQ
Australia
Suite 5 CPC, 145, Stirling Hwy
Melodiol Global Health Financials
Summary Financials
- Revenue (FY, 2023)
- $21.6M
- Gross profit (FY, 2023)
- $2.4M
- Net income (FY, 2023)
- ($52.4M)
- Cash (FY, 2023)
- $692.0K
- EBIT (FY, 2023)
- ($43.2M)
- Enterprise value
- $140.4M
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026